Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-09-26
1985-02-26
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546164, 546165, 544250, C07D48717, C07D21500, A61K 31505
Patent
active
045018901
ABSTRACT:
Trans-(.+-.)-2-Amino or substituted amino-4-permissibly-substituted 6-lower alkyl or allyl-5,5a,-6,7,8,9,9a,10-octahydropyrimido[4,5-g]quinolines, the corresponding trans-(-)-stereoisomers and salts thereof, useful in treating anxiety, Parkinson's Syndrome, sexual dysfunction, depression, hypertension and elevated prolactin levels, and intermediates useful for the synthesis thereof.
REFERENCES:
patent: 4198415 (1980-04-01), Kornfeld et al.
Kornfeld Edmund C.
Nichols Cynthia L.
Daus Donald G.
Eli Lilly and Company
Rowe James L.
Shen Cecilia
Whale Arthur R.
LandOfFree
Trans-( .+-.)-2,4,6-substituted-5,5a,6,7,8,9,9a,10-octahydro-pyr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Trans-( .+-.)-2,4,6-substituted-5,5a,6,7,8,9,9a,10-octahydro-pyr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Trans-( .+-.)-2,4,6-substituted-5,5a,6,7,8,9,9a,10-octahydro-pyr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-517428